Anonymous
Guest
Anonymous
Guest
When Aciphex goes off patent how much revenue will be lost? What are the FY 12 sales? What will be the impact to reps and Mfg. operations? Is this the next cliff or overblown?
When Aciphex goes off patent how much revenue will be lost? What are the FY 12 sales? What will be the impact to reps and Mfg. operations? Is this the next cliff or overblown?
I need some aciphex to help with all the coney sauce I had on my chili cheese dog to drop on OB's door step
Scup hex sales have diminished quarter over quarter. 23 has been shelved. Belviq and Fycopa are gOing to create solvency for us.
When Aciphex goes off patent how much revenue will be lost? What are the FY 12 sales? What will be the impact to reps and Mfg. operations? Is this the next cliff or overblown?
When Aciphex goes off patent how much revenue will be lost? What are the FY 12 sales? What will be the impact to reps and Mfg. operations? Is this the next cliff or overblown?
Aciphex brings in $600million, dacogen $200 million and aricept 23 @$65 million. All off patent mid to late year 2013. That adds up close to $900 million. Plus halaven quota was $180 and probably underperform at $150 million. Belviq and fycompa need to sell a hell of alot to mKe up for $900 million. Good luck my friends. It's is going to be a bumpy ride.
How about Aloxi?
Thought Aloxi was not being produced, some issue with manufacturing - (FDA) drift from original submission approval.
If you are counting on Belviq to save the day you are sadly mistaken. The launch is being handled by idiots more concerned in booty calls and fluff than sales and market share. They lost solvency the moment they steered hiring toward escort professionals instead of medical professionals.